Boone Health Launches Lymphedema Prevention Program
The new initiative uses bioimpedance technology to monitor fluid levels in breast cancer patients.
Updated on Oct. 23, 2026 in Cancer
Live Poll
Do you trust your local healthcare providers to prioritize your long-term recovery and quality of life?
Boone Health has introduced a specialized lymphedema prevention program for breast cancer patients to identify subclinical signs of swelling early. The initiative employs advanced bioimpedance spectroscopy technology to track fluid-level changes.
Why it matters
Early detection allows for intervention before visible swelling occurs, potentially improving long-term outcomes for patients. The program provides a structured approach to monitoring based on individual risk factors and treatment history.
The program utilizes the SOZO Digital Health Platform to monitor fluid-level changes through bioimpedance spectroscopy. It follows a structured Test, Trigger and Treat model to guide intervention strategies for breast cancer patients.
The players
Boone Health
A healthcare provider based in Columbia that is offering new specialized lymphedema services.
Boone Therapy
A rehabilitation partner that provides manual lymphatic drainage and therapeutic exercises for cancer patients.
The details
Boone Health Breast Care partners with Boone Therapy to provide manual lymphatic drainage, therapeutic exercises, and compression garments. Patients receive baseline measurements and ongoing follow-up assessments tailored to their treatment histories.
Timeline
Boone Health announced the launch of the program on October 23, 2026.
Health Landscape
This program utilizes the SOZO Digital Health Platform to advance the standard of care for post-surgical oncology patients. It represents a shift toward proactive, technology-driven monitoring in chronic condition management compared to traditional observation.
Breast cancer patients at Boone Health can now access proactive monitoring to manage fluid buildup before it develops into clinical lymphedema. Individuals can reach out to 573-815-8277 for information regarding appointments and program availability.
The takeaway
Proactive monitoring through bioimpedance spectroscopy allows patients to address subclinical fluid changes immediately. Adhering to baseline testing and follow-up schedules is essential for those undergoing treatment to utilize these preventative services effectively.
Further reading
For more information on support services, visit the Cancer section.
Source note: This article includes information reported by Columbia Daily Tribune.
Live Poll
Do you trust your local healthcare providers to prioritize your long-term recovery and quality of life?
